Jun 15, 2020
Immunic, Inc. Announces First Patients Dosed in its Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19
May 21, 2020
First Light Diagnostics Posters and Abstracts Accepted, Part of ECCMID 2020 Abstract Book
May 07, 2020
InDex Pharmaceuticals Holding AB (publ) Interim Report January - March 2020
Apr 20, 2020
Theravance Biopharma Announces Peer-Reviewed Publication Highlighting TD-1473 Program in the Journal of Crohn's and Colitis
Apr 16, 2020
InDex Pharmaceuticals Advances Cobitolimod Further Towards Phase III Following Successful Interactions With FDA and EMA
Apr 09, 2020
Crohn's & Colitis Foundation Welcomes New National Trustees
Apr 09, 2020
Bridge Biotherapeutics Discloses Interim Results from the First Cohort of Phase 2a Study of BBT-401, an Experimental Drug for Ulcerative Colitis
Mar 31, 2020
InDex Pharmaceuticals Receives Grant From Vinnova for Pre-clinical Development of DIMS Compounds in Inflammation
Mar 09, 2020
Canadians suffering from diarrhea-predominant Irritable Bowel Syndrome (IBS-D) have a new clinically proven option approved by Health Canada
Feb 25, 2020
InDex Pharmaceuticals Publishes Mechanism of Action Data for Cobitolimod in Scientific Journal
Feb 19, 2020
InDex Pharmaceuticals' In-depth Analysis of the CONDUCT Study Confirms the Successful Top Line Results and Supports the Strategy Going Forward
Feb 12, 2020
Synspira Therapeutics and Cystic Fibrosis Foundation Sign Agreement to Develop Broad-spectrum Enzyme Replacement for Malabsorption Syndromes
Feb 12, 2020
Immuron reports diarrhea no.1 health issue for Americans on vacation
Feb 11, 2020
InventHelp Inventor Develops Personal Hygiene Accessory for the Anus (LAX-1098)
Jan 30, 2020
Genedata and the Crohn's & Colitis Foundation Collaborate to Improve Patient Care in Crohn's Disease
Jan 27, 2020
Irritable Bowel Syndrome (IBS) Product Earns Top Spot from TopConsumerReviews.com
Jan 15, 2020
NuMedii, Inc. Announces Pharmaceutical Discovery Collaboration For Ulcerative Colitis
Dec 26, 2019
Bridge Biotherapeutics Announces China NMPA Clearance of IND for BBT-401, a Pellino-1 Inhibitor for UC
Nov 12, 2019
Raising Awareness of Rampant Deadly Infection, "See C. diff" Campaign Aims to Save Lives
Oct 22, 2019
Arena Pharmaceuticals Presented New Data Analyses Demonstrating the Long-Term Safety and Efficacy of Once-Daily Etrasimod in Patients with Moderately to Severely Active Ulcerative Colitis at UEG Week